Trikafta 100-50-75 MG/75MG PKT 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FDDR8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,056
Award facts
- Contract value 100% obligated
- $57,056.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,056.09 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Trikafta 100-50-75 mg/75 mg tablets in packets of 14. The delivery order, issued on December 12, 2025, with an ultimate completion date of December 15, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. Performance will occur at the vendor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide Department of Defense military healthcare facilities worldwide with comprehensive pharmaceutical supplies, including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's selection as a regional prime vendor contractor reflects its demonstrated capability to meet the specialized pharmaceutical requirements of federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FDDR8?
SPE2DR26FDDR8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FDDR8 worth?
The government has obligated $57,056 on SPE2DR26FDDR8.
Is contract SPE2DR26FDDR8 an order under another contract?
Yes. SPE2DR26FDDR8 is a delivery order under SPE2DR25D9102, an indefinite delivery contract.
Was contract SPE2DR26FDDR8 competed?
The extent of competition for SPE2DR26FDDR8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award